Open AccessRNASeq profiling of COVID19‐infected patients identified an EIF2AK2 inhibitor as a potent SARS‐CoV‐2 antiviral
Author(s) -
Jain Sidharth,
Rego Samantha,
Park Steven,
Liu Yiran,
Parn Simone,
Savsani Kush,
Perlin David S.,
Dakshanamurthy Sivanesan
Publication year - 2022
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.1098
Subject(s) - interferon , gene expression profiling , biology , gene , ribavirin , antiviral drug , virology , gene expression , computational biology , bioinformatics , virus , genetics , genotype
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom